PuSH - Publikationsserver des Helmholtz Zentrums München

73 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Dannecker, C. et al.: Low-density lipoprotein cholesterol is associated with insulin secretion. J. Clin. Endocrinol. Metab. 106, 1576-1584 (2021)
2.
Erlic, Z.* et al.: Targeted metabolomics as a tool in discriminating endocrine from primary hypertension. J. Clin. Endocrinol. Metab. 106, 1111-1128 (2021)
3.
Hanschkow, M.* et al.: Expression of the adipocyte progenitor markers MSCA1 and CD36 is associated with adipose tissue function in children. J. Clin. Endocrinol. Metab., DOI: 10.1210/clinem/dgab630 (2021)
4.
Hörber, S.* et al.: Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes. J. Clin. Endocrinol. Metab. 106, E3198-E3207 (2021)
5.
Krug, R.* ; Beier, L.* ; Lämmerhofer, M.* & Hallschmid, M.: Distinct and convergent beneficial effects of estrogen and insulin on cognitive function in healthy young men. J. Clin. Endocrinol. Metab., DOI: 10.1210/clinem/dgab689 (2021)
6.
Lehn-Stefan, A. et al.: Elevated circulating glutamate associates with subclinical atherosclerosis independently of established risk markers: A cross-sectional study. J. Clin. Endocrinol. Metab. 106, e982-e989 (2021)
7.
Rottenkolber, M. et al.: A pathophysiology of type 2 diabetes unrelated to metabolic syndrome. J. Clin. Endocrinol. Metab. 106, 1460-1471 (2021)
8.
Thorand, B. et al.: A panel of six biomarkers significantly improves the prediction of type 2 diabetes in the MONICA/KORA study population. J. Clin. Endocrinol. Metab. 106, e1647-e1659 (2021)
9.
Bardugo, A.* et al.: Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood. J. Clin. Endocrinol. Metab. 106, e34-e44 (2020)
10.
Bornstein, S.R.* et al.: New horizons: Novel adrenal regenerative therapies. J. Clin. Endocrinol. Metab. 105, 3103-3107 (2020)
11.
Hoffmann, C.* et al.: Response of mitochondrial respiration in adipose tissue and muscle to 8 weeks of endurance exercise in obese subjects. J. Clin. Endocrinol. Metab. 105:dgaa571 (2020)
12.
Hu, C.* et al.: Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism. J. Clin. Endocrinol. Metab. 105, 1196–1209 (2020)
13.
Pozzilli, P.* et al.: Randomized 52-week phase 2 trial of albiglutide vs placebo in adult patients with newly diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 105, e2192–e2206 (2020)
14.
Randrianarisoa, E. et al.: AMPK subunits harbor largely non-overlapping genetic determinants for body fat mass, glucose- and cholesterol metabolism. J. Clin. Endocrinol. Metab. 105, 14-25:dgz020 (2020)
15.
Tofte, N.* et al.: Plasma metabolomics identifies markers of impaired renal function: A meta-analysis of 3,089 persons with type 2 diabetes. J. Clin. Endocrinol. Metab. 105:dgaa173 (2020)
16.
Wagner, R. et al.: Pancreatic steatosis associates with impaired insulin secretion in genetically predisposed individuals. J. Clin. Endocrinol. Metab. 105:dgaa435 (2020)
17.
Capristo, E.* et al.: Incidence of hypoglycemia after gastric bypass vs sleeve gastrectomy: A randomized trial. J. Clin. Endocrinol. Metab. 104, 732-733 (2019)
18.
Gerards, J.* et al.: Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J. Clin. Endocrinol. Metab. 104, 3192-3202 (2019)
19.
Kempe-Teufel, D. et al.: A polygenic risk score of lipolysis-increasing alleles determines visceral fat mass and proinsulin conversion. J. Clin. Endocrinol. Metab. 104, 1090-1098 (2019)
20.
Lutz, S.Z. et al.: The Gly385(388)arg polymorphism of the FGFR4 receptor regulates hepatic lipogenesis under healthy diet. J. Clin. Endocrinol. Metab. 104, 2041-2053 (2019)